---
figid: PMC8583797__ijms-22-11490-g009
figtitle: Tenofovir Modulates Semaphorin 4D Signaling and Regulates Bone Homeostasis,
  Which Can Be Counteracted by Dipyridamole and Adenosine A2A Receptor
organisms:
- Homo sapiens
- Mus musculus
- Human immunodeficiency virus 1
- Nymphalis l-album
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC8583797
filename: ijms-22-11490-g009.jpg
figlink: /pmc/articles/PMC8583797/figure/ijms-22-11490-f009/
number: F9
caption: 'Proposed pathway for tenofovir and Sema4D. Tenofovir promotes Sema4D secretion
  from osteoclast, and activation of PlexinB1 in osteoblast, activation of RhoA phosphorylation
  and ROCK1 activation and inhibition of IGF1R/IRS1. Treatment with compounds that
  increase extracellular adenosine levels, such as dipyridamole, can revert this effect.
  OC: osteoclast; OB: osteoblast, A2AR: adenosine A2A receptor: Ent1: Equilibrative
  nucleoside transporter1; Sema 4D: Semaphorin 4D; ERBB2: receptor tyrosine-protein
  kinase erbB-2. Vav3:Vav Guanine Nucleotide Exchange Factor 3: ARHGAP18: Rho GTPase
  Activating Protein 18. IGF1: insulin-like growth factor-1; IRS1: Insulin receptor
  substrate 1.'
papertitle: Tenofovir Modulates Semaphorin 4D Signaling and Regulates Bone Homeostasis,
  Which Can Be Counteracted by Dipyridamole and Adenosine A2A Receptor.
reftext: Patricia Llamas-Granda, et al. Int J Mol Sci. 2021 Nov;22(21):11490.
year: '2021'
doi: 10.3390/ijms222111490
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: Sema4D | tenofovir | bone turnover | HIV | adenosine A2A receptor | osteoblast
automl_pathway: 0.941573
figid_alias: PMC8583797__F9
figtype: Figure
redirect_from: /figures/PMC8583797__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8583797__ijms-22-11490-g009.html
  '@type': Dataset
  description: 'Proposed pathway for tenofovir and Sema4D. Tenofovir promotes Sema4D
    secretion from osteoclast, and activation of PlexinB1 in osteoblast, activation
    of RhoA phosphorylation and ROCK1 activation and inhibition of IGF1R/IRS1. Treatment
    with compounds that increase extracellular adenosine levels, such as dipyridamole,
    can revert this effect. OC: osteoclast; OB: osteoblast, A2AR: adenosine A2A receptor:
    Ent1: Equilibrative nucleoside transporter1; Sema 4D: Semaphorin 4D; ERBB2: receptor
    tyrosine-protein kinase erbB-2. Vav3:Vav Guanine Nucleotide Exchange Factor 3:
    ARHGAP18: Rho GTPase Activating Protein 18. IGF1: insulin-like growth factor-1;
    IRS1: Insulin receptor substrate 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC29A1
  - SEMA4D
  - ERBB2
  - RHOA
  - PLXNB1
  - VAV3
  - ROCK1
  - IRS1
  - IGF1R
  - Slc29a1
  - Sema4d
  - Erbb2
  - Rhoa
  - Vav3
  - Rock1
  - Irs1
  - Igf1r
  - sema4d
  - erbb2
  - rhoaa
  - rhoab
  - vav3
  - rock1
  - irs1
---
